CNS Drugs Take Longer to Develop, Win Approval

September 19, 2018

Drugs targeting the central nervous system take significantly longer to develop and get approved than other meds, according to a new analysis. In fact, the report cites that CNS drugs took 20% longer to develop and about 19 months (36%) longer on average than other meds to win FDA approval after clinical trials. 

No Previous Flipbooks

Next Flipbook
Detecting cognitive changes in preclinical Alzheimer’s disease: A review of its feasibility
Detecting cognitive changes in preclinical Alzheimer’s disease: A review of its feasibility

Significant progress has been made in characterizing the biological changes occurring in preclinical Alzhei...